Drugs / Dendritic cell vaccine with mRNA from tumor stem cells
Dendritic cell vaccine with mRNA from tumor stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00846456 | Jan 2009 → Feb 2013 | brain neoplasm, glioblastoma | Oslo University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic cell vaccine with mRNA from tumor stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00846456 ↗ |
| Modality | Vaccine | “Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.” PMID 23817721 ↗ Jul 2013 |